Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 20, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kymera Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 18
| |||||||
Beam Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 5
| |||||||
Rapport Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Prokidney Corp.
|
0
|
—
|
—
|
—
|
0
|
Jun 29
| |||||||
Kymera Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Beam Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Beam Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 1
| |||||||
Prokidney Corp.
|
0
|
—
|
—
|
—
|
0
|
Jul 11
| |||||||
Prokidney Corp.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Agios Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 21
| |||||||
Agios Pharmaceuticals, Inc.
| 1.58K |
—
|
—
| +5.57% | 30.03K |
May 20
| |||||||
Kymera Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 18
| |||||||
Kymera Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Alnylam Pharmaceuticals, Inc.
| 7.53K |
$188.98 | -$1,254,077.33 | +3.42% | 227.66K |
Dec 21 - Dec 22
| |||||||
Alnylam Pharmaceuticals, Inc.
| 5.37K |
$74.50 | $399,829.03 | +2.50% | 220.13K |
Dec 10
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$89.31 | -$5,586,556.81 |
—
| 214.76K |
Nov 12
|
Scheduled
| ||||||
Beam Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 5
| |||||||
Beam Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$103.44 | -$6,546,945.06 |
—
| 214.76K |
Aug 13
|
Scheduled
| ||||||
Agios Pharmaceuticals, Inc.
| -1.73K |
—
|
—
| -5.73% | 28.44K |
Feb 4 - May 28
| |||||||
Agios Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 20
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$68.94 | -$4,202,473.99 |
—
| 214.76K |
May 13
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| 8.73K |
$131.85 | -$989,822.04 | +4.24% | 214.76K |
Apr 19 - Apr 20
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$77.21 | -$4,764,170.36 |
—
| 206.04K |
Feb 24 - Feb 25
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| 8.45K |
$155.78 | -$890,916.66 | +4.28% | 206.04K |
Feb 11 - Feb 12
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$66.69 | -$4,001,273.05 |
—
| 197.59K |
Nov 19
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$72.63 | -$4,414,790.13 |
—
| 197.59K |
Aug 20
|
Scheduled
| ||||||
Agios Pharmaceuticals, Inc.
| 1.88K |
—
|
—
| +6.64% | 30.17K |
May 28 - May 29
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$76.18 | -$4,661,230.96 |
—
| 197.59K |
May 20
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| 7.6K |
$104.81 | -$688,701.37 | +4.00% | 197.59K |
Apr 7
| |||||||
Agios Pharmaceuticals, Inc.
| -4.32K |
—
|
—
| -13.23% | 28.29K |
Feb 14
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 26
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$70.50 | -$4,265,922.19 |
—
| 189.99K |
Feb 20
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 23
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 22
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$47.94 | -$3,116,648.26 |
—
| 189.99K |
Oct 14
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| 34 |
—
|
—
| +1.10% | 3.13K |
Jul 11 - Aug 6
| |||||||
Agios Pharmaceuticals Inc
| -5.00K |
—
|
—
| -13.29% | 32.61K |
Jun 12
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 5
| |||||||
Agios Pharmaceuticals Inc
| 1.4K |
—
|
—
| +3.87% | 37.61K |
May 29 - May 31
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.